Bone Therapeutics is Biotechnology in Belgium that focus on spinal fusion business. Founded in 2006. They cover business area such as Bone Therapeutics SA, cell therapy product, orthopaedic and bone disease, ALLOB, treatment, delay-union fracture, spinal fusion procedure, revision spinal fusion, PREOB, addition, preclinical research, next-generation product candidate, combine cell-matrix product, large bone defect, maxillofacial application.
2006
( 18 years old in 2024 )
Spinal Fusion
-
Rue Auguste Piccard, 37
6041 Gosselies
Belgium
Private
Bone Therapeutics SAcell therapy productorthopaedic and bone diseaseALLOBtreatmentdelay-union fracturespinal fusion procedurerevision spinal fusionPREOBadditionpreclinical researchnext-generation product candidatecombine cell-matrix productlarge bone defectmaxillofacial application
* We use standard office opening hours in near Bone Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bone Therapeutics is Biotechnology business from Belgium that founded in 2006 (18 years old in 2024), Bone Therapeutics business is focusing on Spinal Fusion.
Bone Therapeutics headquarter office and corporate office address is located in Rue Auguste Piccard, 37 6041 Gosselies Belgium.
Bone Therapeutics was founded in Belgium.
In 2024, Bone Therapeutics is currently focus on spinal fusion sector.
Above is snippet of Google Trends for "spinal fusion" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bone Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
